CAPLIN POINT LABORATORIES
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Caplin Point Laboratories along with daily highs, lows, percentage changes and volume trends, and, all financial information.
0.16₹ 3.25
As on Oct 31, 2025, 4:01 PM IST
Caplin Point Laboratories Price Performance
Today's LowToday's High
₹2,014.05₹2,045.90
₹2,033.40
52 Weeks' Low52 Weeks' High
₹1,551.05₹2,636.00
₹2,033.40
Open Price
₹2,031.00
Prev. Close
₹2,030.15
Volume
1,678
Over the last 5 years, the share price of Caplin Point Laboratories has gained 33.16% CAGR. Over the past year, the corresponding return has been -0.11%.
Caplin Point Laboratories’s current P/E of 27.35x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.
Caplin Point Laboratories Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Caplin Point Laboratories | 1.60 | -1.13 | -1.71 | 7.91 | -0.11 | 40.97 | 33.16 |
| Sun Pharmaceutical Industries | -0.57 | 3.28 | -0.92 | -7.60 | -8.61 | 18.48 | 29.21 |
| Divi's Laboratories | 2.65 | 18.41 | 2.45 | 10.85 | 14.73 | 23.31 | 17.28 |
| Cipla | -5.18 | -0.81 | -3.38 | -1.58 | -3.32 | 8.79 | 14.87 |
| Torrent Pharmaceuticals | -0.80 | -0.38 | -5.14 | 9.01 | 10.85 | 29.10 | 22.78 |
| Dr. Reddy's Laboratories | -6.61 | -3.78 | -5.65 | 1.37 | -5.90 | 10.60 | 4.30 |
| Mankind Pharma | -2.15 | -2.43 | -7.34 | -0.11 | -10.77 | 18.66 | 10.81 |
| Zydus Lifesciences | -3.15 | -1.79 | 0.41 | 10.00 | -2.78 | 30.95 | 18.88 |
| Lupin | 1.95 | -0.64 | 2.09 | -4.31 | -9.93 | 41.27 | 16.64 |
| Aurobindo Pharma | 4.93 | 4.74 | -0.20 | -6.06 | -18.43 | 28.36 | 8.42 |
| Alkem Laboratories | -0.73 | 0.83 | 9.42 | 8.53 | -4.81 | 20.39 | 15.68 |
| Abbott India | -3.15 | -2.92 | -15.75 | -5.70 | 0.08 | 14.62 | 13.33 |
| Glenmark Pharmaceuticals | 3.96 | -3.48 | -11.38 | 37.43 | 11.65 | 67.21 | 31.92 |
| Laurus Labs | 3.16 | 9.45 | 9.18 | 53.86 | 94.04 | 28.05 | 25.98 |
| Biocon | 3.58 | 7.36 | -4.88 | 16.74 | 17.67 | 11.37 | -1.64 |
| GlaxoSmithKline Pharmaceuticals | -4.58 | -2.61 | -16.91 | -8.00 | -3.51 | 23.97 | 13.24 |
| Anthem Biosciences | -1.31 | -7.94 | -6.37 | -2.73 | -2.73 | -0.92 | -0.55 |
| Ipca Laboratories | 0.17 | -4.35 | -13.80 | -7.87 | -20.02 | 11.98 | 2.00 |
| Gland Pharma | -0.60 | -2.66 | -6.66 | 37.25 | 16.79 | 2.61 | 1.15 |
| Ajanta Pharma | 2.22 | 2.85 | -10.32 | -4.54 | -19.69 | 23.86 | 18.63 |
Over the last one year, Caplin Point Laboratories has declined 0.11% compared to peers like Sun Pharmaceutical Industries (-8.61%), Divi's Laboratories (14.73%), Cipla (-3.32%). From a 5 year perspective, Caplin Point Laboratories has outperformed peers relative to Sun Pharmaceutical Industries (29.21%) and Divi's Laboratories (17.28%).
Caplin Point Laboratories Financials
Caplin Point Laboratories Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 2,017.41 | 2,019.86 |
| 10 | 2,008.65 | 2,019.22 |
| 20 | 2,013.05 | 2,036.71 |
| 50 | 2,119.47 | 2,075.18 |
| 100 | 2,092.15 | 2,080.07 |
| 200 | 2,058.3 | 2,039.45 |
Caplin Point Laboratories Share Holding Pattern
In the latest quarter, Caplin Point Laboratories saw a rise in promoter holding to 70.59%, while DII stake decreased to 2.10%, FII holding rose to 6.51%, and public shareholding moved down to 20.82% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Caplin Point Laboratories Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 2,55,019 | 0.79 | 50.14 | |
| 2,30,984 | 0.91 | 45.41 | |
| 1,30,837 | 2.35 | 25.72 | |
| 1,07,069 | 0.45 | 21.05 |
* Excluding Index & Arbitrage Funds
Caplin Point Laboratories Corporate Actions
Date Time | Announcement |
|---|---|
| Oct 30, 2025, 12:42 AM IST | Caplin Point Lab - Board Meeting Intimation for Considering And Approving The Unaudited Financial Results Of The Company For |
| Oct 30, 2025, 12:11 AM IST | Caplin Point Lab - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Oct 30, 2025, 12:03 AM IST | Caplin Point Lab - Board Meeting Intimation for Considering And Approving, Inter-Alia, The Unaudited Financial Results Of The |
| Oct 23, 2025, 8:19 PM IST | Caplin Point Lab - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Oct 04, 2025, 7:33 PM IST | Caplin Point Lab - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
About Caplin Point Laboratories
Caplin Point Laboratories Ltd. is a Public Limited Listed company incorporated on 16/04/1990 and has its registered office in the State of Tamil Nadu, India. Company's Corporate Identification Number(CIN) is L24231TN1990PLC019053 and registration number is 019053. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 752.41 Cr. and Equity Capital is Rs. 15.20 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- Address3rd Floor, Ashvich Towers, No.3, Developed Plots Industrial Chennai (Madras) Tamil Nadu 600096
- Contact
Management
- Mr. C C PaarthipanChairman
- Dr. Sridhar GanesanManaging Director
- Dr. R NagendranIndependent Director
- Mr. S DeenadayalanIndependent Director
- Dr. C K GariyaliIndependent Director
- Mr. R VijayaraghavanIndependent Director
FAQs on Caplin Point Laboratories Share Price
What is the share price of Caplin Point Laboratories?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Caplin Point Laboratories is ₹2,033.40 as on Oct 31, 2025.
What kind of stock is Caplin Point Laboratories?
The Caplin Point Laboratories is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Caplin Point Laboratories?
The market cap of Caplin Point Laboratories is ₹15,456.22 Cr as on Oct 31, 2025.
What are today's High and Low prices of Caplin Point Laboratories?
Today’s highest and lowest price of Caplin Point Laboratories are ₹2,045.90 and ₹2,014.05.
What are the 52 Week High and 52 Week Low of Caplin Point Laboratories?
The 52-week high/low is the highest and lowest price at which Caplin Point Laboratories stock has traded in the past 52-week or nearly a year. The 52-week high of Caplin Point Laboratories is ₹2,636.00 and 52-week low of Caplin Point Laboratories is ₹1,551.05 as on Oct 31, 2025.
How has the Caplin Point Laboratories performed historically in terms of returns?
The Caplin Point Laboratories has shown returns of 0.16% over the past day, -1.13% for the past month, -1.71% over 3 months, -0.11% over 1 year, 40.97% across 3 years, and 33.16% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Caplin Point Laboratories?
P/E ratio of and PB ratio of Caplin Point Laboratories are 27.35 and 6.08 on Oct 31, 2025. While the company gives a dividend yield of 0.30 per annum.
Caplin Point Laboratories News
✕
Market Pulse